Skip to main content
. 2022 Aug 26;14(17):4123. doi: 10.3390/cancers14174123

Figure 2.

Figure 2

Nanoparticle-based delivery of siRNA and gemcitabine functionalized with targeting moiety, which delivers drug and Mcl-2 siRNA to cancer cells and helps to combat resistance.